Latest Novo Ventures Stories
Chief Medical Officer Appointed to Advance Growing Portfolio; Series A Extension Earmarked for Second Product Candidate Preclinical Development SAN CARLOS, Calif., Sept.
VIENNA, Austria, April 13, 2011 /PRNewswire/ -- - To Progress Product Candidates Into Development and Maximise Potential of the Modular Antibody Technology Platform f-star GmbH, a biopharmaceutical company developing a new generation of antibody based products using its Modular Antibody Technology platform, today announced the closing of a EUR 15 Million financing.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.